AI reads your gut scans to spot disease without a scope

NCT ID NCT07087418

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is developing an artificial intelligence system that analyzes CT and MRI scans to diagnose and predict outcomes for digestive diseases like Crohn's disease, ulcerative colitis, and intestinal tuberculosis. Researchers are using data from 21 hospitals in China to train the AI, and will test it in two additional hospitals. The goal is to create a noninvasive tool that could reduce the need for colonoscopies and help doctors make faster, more accurate decisions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

AI diagnostic model using CT and MR imaging

What this could lead to

If successful, this could provide a noninvasive way to diagnose and predict the course of digestive diseases, potentially reducing the need for colonoscopies.

What could go wrong

This is an observational study, not a treatment trial. The AI model may not perform as well in real-world settings or in different populations, and it is still being tested for accuracy.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CROHN DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Behcet disease Crohn disease Digestive System Diseases digestive system disorder intestinal tuberculosis ulcerative colitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • XploreMET v3.0 system

    RECRUITING

    Shanghai, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••